Keyphrases
Diagnostic Accuracy
100%
Atypical Parkinsonism
100%
18F-FDG Positron Emission Tomography
100%
Confidence Interval
33%
Clinical Diagnosis
33%
Multiple System Atrophy
33%
Corticobasal Degeneration
33%
Progressive Supranuclear Palsy
33%
Clinical Treatment
16%
Dementia with Lewy Bodies
16%
Clinical Criteria
16%
Supportive Treatment
16%
High Specificity
16%
Prognosis Treatment
16%
Dopamine Transporter Imaging
16%
High Sensitivity
16%
Parkinson's Symptoms
16%
Dementia
16%
Clinical Information
16%
D-glucose
16%
Treatment Trials
16%
Patient Demographics
16%
Long-term Prognosis
16%
Nuclear Medicine
16%
Overall Accuracy
16%
Parkinson
16%
Positron Emission Tomography
16%
Fluoro
16%
Medicine and Dentistry
Fluorodeoxyglucose F 18
100%
Atypical Parkinsonism
100%
Diagnostic Accuracy
100%
Positron Emission Tomography
100%
Sensitivity and Specificity
28%
Progressive Supranuclear Palsy
28%
Corticobasal Degeneration
28%
Shy-Drager Syndrome
28%
Disease
14%
Symptom
14%
Dopamine Transporter
14%
Patient Population
14%
Nuclear Medicine
14%
Diffuse Lewy Body Disease
14%
Pharmacology, Toxicology and Pharmaceutical Science
Fluorodeoxyglucose F 18
100%
Parkinsonism
100%
Progressive Supranuclear Palsy
28%
Corticobasal Degeneration
28%
Shy Drager Syndrome
28%
Disease
14%
Symptom
14%
Diffuse Lewy Body Disease
14%
Dopamine Transporter
14%
